DXR Daxor Corporation

10.51USD+2.04%Mkt Cap: 61.36M $P/E: 9.55

Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use …

Key Statistics

Company
Market Cap61.36M USD
Enterprise Value—
Revenue (TTM)31.36K USD
Gross Profit31.36K USD
Net Income (TTM)9.17M USD
Revenue/Share0.0050 USD
Last Price10.51 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)9.55
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S1917.55
P/B1.16
EPS (TTM)1.06
EPS (Forward)—
52W Range
8.56031% of range14.76
52W High14.76 USD
52W Low8.560 USD
Profitability
Gross Margin100.00%
Oper. Margin-4529.86%
EBITDA Margin0.00%
Profit Margin89.00%
ROE19.98%
ROA19.93%
Growth
Revenue Growth25.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF570.94K USD
CapEx (TTM)—
FCF Margin1064.63%
FCF Yield0.54%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio2.88
Quick Ratio—
Book Value/Sh8.88 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield0.44%
Payout Ratio0.00%
Ex-Div DateJan 5, 2018
Pay DateJan 12, 2018
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Upside (mean)+90.3%
Target Range18.00 USD – 22.00 USD
18.00+90.3% to mean22.00
# Analysts2
Ownership
Shares Out.5.84M
Float2.90M
Insiders49.50%
Institutions7.02%
Short Interest
Short Ratio0.1d
Short % Float0.08%
Short % Out.0.04%
Shares Short2.33K
Short (prev mo.)306
Technical
SMA 5010.66 (-1.4%)
SMA 20011.09 (-5.2%)
Beta0.35
S&P 52W Chg16.45%
Avg Vol (30d)33.05K
Avg Vol (10d)18.81K
Technical Indicators
RSI (14)45.5
MACD-0.0063
MACD Signal0.1158
MACD Hist.-0.1221
BB Upper11.88 USD
BB Middle11.05 USD
BB Lower10.22 USD
BB Width14.99%
ATR (14)0.6827 USD
Vol Ratio (20d)0.16x